Publications

Different independent associations of depression and anxiety with survival in patients with cancer
18 Aug 2020 in Journal of Psychosomatic Research
Research output: Contribution to Journal › Article (Published)

Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT oncology-2 and 3 trials
14 Nov 2018 in Journal of Psychosomatic Research
DOI: https://doi.org/10.1016/j.jpsychores.2018.11.008
Research output: Contribution to Journal › Article (Published)

Does depression treatment improve the survival of depressed cancer patients? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.
12 Mar 2018 in Lancet Psychiatry
DOI: https://doi.org/10.1016/S2215-0366(18)30061-0
Research output: Contribution to Journal › Article (Published)

1211TiPFAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizumab) inhibition
1 Sep 2017 in Annals of Oncology, vol. 28
DOI: https://doi.org/10.1093/annonc/mdx376.071
Research output: Contribution to Journal › Meeting abstract (Published)

FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
21 Feb 2017 in Journal for immunotherapy of cancer, vol. 5, pp. 17
DOI: https://doi.org/10.1186/s40425-017-0217-6
Research output: Contribution to Journal › Article (Published)

View all 14 publications on Research Explorer

Data last updated: 24/11/2020 at 10:51